Literature DB >> 1785335

C-peptide/creatinine ratio in early morning urine as an indicator of residual B-cell function in insulin-dependent diabetes.

N Sasaki1, S Miyamoto, H Niimi, H Nakajima.   

Abstract

The C-peptide/creatinine (Cr) ratio in early morning urine was evaluated to assess B-cell function. The subjects were 12 boys and 36 girls with insulin-dependent diabetes mellitus (IDDM). The controls were 130 boys and 137 girls aged 4-15 years. There was a significant inverse correlation of this ratio with the duration of insulin therapy (r = -0.5807, P less than 0.01). The daily insulin dose in U/kg was significantly different among the following groups: 1.22 +/- 0.31 U/kg in group 1 with undetectable C-peptide, 0.94 +/- 0.37 in group 2 with a decreased ratio and 0.45 +/- 0.28 in group 3 with a normal ratio. HbA1 levels were 11.3 +/- 1.6% in group 1 and 9.2 +/- 1.1% in group 3. The difference was significant. The result shows that the C-peptide/Cr ratio in early morning urine is useful for assessing B-cell function in diabetic children.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1785335     DOI: 10.1111/j.1442-200x.1991.tb01569.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  2 in total

1.  Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.

Authors:  Rachel E J Besser; Johnny Ludvigsson; Angus G Jones; Timothy J McDonald; Beverley M Shields; Bridget A Knight; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2011-02-01       Impact factor: 19.112

2.  Post-glucose-load urinary C-peptide and glucose concentration obtained during OGTT do not affect oral minimal model-based plasma indices.

Authors:  Sjaam Jainandunsing; J L Darcos Wattimena; Trinet Rietveld; Joram N I van Miert; Eric J G Sijbrands; Felix W M de Rooij
Journal:  Endocrine       Date:  2015-11-02       Impact factor: 3.633

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.